Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ubasawa

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|July 1, 1991
Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitroM Baba, M Ito, S Shigeta, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991
Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptaseM Baba, E De Clercq, H Tanaka, et al.
Journal of Medicinal Chemistry|April 1, 1991
Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymineH Tanaka, M Baba, S Saito, et al.
Biochemical Pharmacology|June 22, 1993
Effect of human serum on the in vitro anti-HIV-1 activity of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives as related to their lipophilicity and serum protein bindingM Baba, S Yuasa, T Niwa, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1990
Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivativesM Baba, E De Clercq, S Iida, et al.
Molecular Pharmacology|June 1, 1991
Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivativesM Baba, E De Clercq, H Tanaka, et al.
Journal of Medicinal Chemistry|December 11, 1992
Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agentsH Tanaka, H Takashima, M Ubasawa, et al.
Journal of Medicinal Chemistry|April 1, 1991
Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)H Tanaka, M Baba, M Ubasawa, et al.
Journal of Medicinal Chemistry|January 24, 1992
Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activityH Tanaka, H Takashima, M Ubasawa, et al.
Journal of Medicinal Chemistry|July 21, 1995
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agentsH Tanaka, H Takashima, M Ubasawa, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|July 1, 1991
Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitroM Baba, M Ito, S Shigeta, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991
Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptaseM Baba, E De Clercq, H Tanaka, et al.
Journal of Medicinal Chemistry|April 1, 1991
Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymineH Tanaka, M Baba, S Saito, et al.
Biochemical Pharmacology|June 22, 1993
Effect of human serum on the in vitro anti-HIV-1 activity of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives as related to their lipophilicity and serum protein bindingM Baba, S Yuasa, T Niwa, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1990
Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivativesM Baba, E De Clercq, S Iida, et al.
Molecular Pharmacology|June 1, 1991
Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivativesM Baba, E De Clercq, H Tanaka, et al.
Journal of Medicinal Chemistry|December 11, 1992
Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agentsH Tanaka, H Takashima, M Ubasawa, et al.
Journal of Medicinal Chemistry|April 1, 1991
Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)H Tanaka, M Baba, M Ubasawa, et al.
Journal of Medicinal Chemistry|January 24, 1992
Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activityH Tanaka, H Takashima, M Ubasawa, et al.
Journal of Medicinal Chemistry|July 21, 1995
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agentsH Tanaka, H Takashima, M Ubasawa, et al.
Pageof 3